Management of Polyposis Syndrome in a 26-Year-Old Female with Hematochezia
For a 26-year-old female with polyposis syndrome diagnosed on colonoscopy for hematochezia, genetic testing should be performed immediately to identify the specific syndrome type, followed by appropriate surveillance and consideration of prophylactic surgery based on the genetic findings.
Initial Evaluation and Genetic Testing
- Genetic testing should be performed to identify the specific polyposis syndrome (FAP, attenuated FAP, MUTYH-associated polyposis, Lynch syndrome, Peutz-Jeghers syndrome, or juvenile polyposis) 1
- Full germline genetic testing should include DNA sequencing and large rearrangement analysis 1
- Testing should include evaluation for APC mutations (for FAP) and MUTYH mutations, with consideration of other genes based on clinical presentation 1, 2
- The patient's twin sister should also undergo genetic testing and appropriate surveillance given the high likelihood of shared genetic risk 1
Management Based on Syndrome Type
If Familial Adenomatous Polyposis (FAP) is confirmed:
- Prophylactic colectomy is strongly recommended between ages 16-25 years to prevent colorectal cancer development 1
- The surgical approach depends on polyp burden:
- The decision on surgical approach should consider age, severity of rectal polyposis, desire for future childbearing, and risk of developing desmoids 1
If Attenuated FAP is confirmed:
- Colonoscopy should be performed every 1-2 years 1
- Some patients with AFAP can be managed conservatively with regular colonoscopy and polypectomy 1
- Surgery is indicated if there are large numbers of adenomas or adenomas showing high-grade dysplasia 1
If Juvenile Polyposis Syndrome is confirmed:
- Colonoscopic surveillance should continue at 1-3 year intervals, personalized according to colorectal phenotype 1
- Polypectomy at surveillance is recommended to prevent polyp-related complications 1
If Peutz-Jeghers Syndrome is confirmed:
- Colonoscopic surveillance every 3 years 1
- Small bowel polyps >1.5-2 cm should be considered for elective resection to prevent intussusception 1
Additional Surveillance Recommendations
Upper gastrointestinal endoscopy should be performed to evaluate for gastroduodenal polyps 1
For female patients with Lynch syndrome (if diagnosed):
Annual thyroid ultrasound should be considered in FAP patients starting at age 25-30 years 1
Screening for Family Members
- First-degree relatives (including the twin sister) should undergo genetic testing if a pathogenic mutation is identified 1
- If genetic testing is negative or uninformative, clinical surveillance should begin at an age 5-10 years younger than the earliest diagnosis in the family 1, 2
Lifestyle Modifications and Chemoprevention
- Patients should be strongly encouraged not to smoke, maintain normal BMI, moderate consumption of red and processed meat, and exercise regularly 1
- For Lynch syndrome (if diagnosed), daily aspirin use should be recommended as it reduces colorectal cancer risk 1
- There is insufficient evidence for chemoprevention in other polyposis syndromes 1, 2
Follow-up After Surgery
- After colectomy with ileorectal anastomosis, the rectum must be kept under review at least annually for life due to 12-29% risk of cancer in the retained rectum 1
- After proctocolectomy with ileal pouch-anal anastomosis, the anorectal cuff should be kept under annual review for life 1
- Surveillance of the pouch should be carried out every 6-12 months if rectal tissue remains and every 6 months to 5 years if ileoanal pouch, depending on polyp burden 1
Common Pitfalls to Avoid
- Delaying genetic testing or surgical intervention in patients with clear evidence of FAP, as colorectal cancer risk is extremely high 1, 4
- Failing to screen for extracolonic manifestations, which can lead to missed diagnoses of associated cancers 1
- Inadequate bowel preparation leading to missed polyps; repeat examination should be arranged within 3 months if preparation is inadequate 1
- Overlooking the need for high-quality colonoscopy by endoscopists who consistently achieve minimum standards for caecal intubation rate and adenoma/polyp detection rate 1